Tiger Global-backed Algorithmiq to collaborate with IBM over drug discovery using Quantum

Tech

Products You May Like

Algorithmiq, a Helsinki-based quantum computing startup, has pulled in a deal with IBM to super-charge its exploration of quantum algorithms applied to the life sciences. The collaboration will attempt to dramatically cut the time and cost of drug discovery and development. The widely accepted maxim is that it takes around a decade and $1 billion for a new drug to get to market.

The move plans to also contribute to Qiskit, an open-source SDK for quantum computers. Algorithmiq will therefore become part of the IBM Quantum Network.

In February this year, Algorithmiq announced a $4m seed round backed by investment from Tiger Global, K5 Global and various angel investors.

Headed by Co-Founder, and Professor, Sabrina Maniscalco, Algorithmiq also won the honour of being the “Hottest DeepTech Startup In Europe” award at the long-standing Europas Awards, held this year in in Lisbon, which has been running for 14 years and is judged solely by investors, founders, and journalists.

Products You May Like

Articles You May Like

Denzel Curry Enlists Lazer Dim 700 and Bktherula for New Song and Video: Watch
China chooses 2 teams to develop low-cost space station cargo spacecraft
Marvel Legends 2025 Figures Revealed: Dark Ms. Marvel Warbird! Fabian Cortez! Spot!
‘Godzilla Minus One’ Stomps Back Into Theaters – Specialty Preview  
Mario & Luigi: Brothership Estimated Switch File Size Update